NEW YORK (Reuters Health) – In patients with newly diagnosed type 1 diabetes, high-dose immune ablation followed by autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) induces significant and…
NEW YORK (Reuters Health) – In children exposed in utero to methamphetamine, MRI findings suggest alterations in white matter maturation, according to a report in the April 15th…
NEW YORK (Reuters Health) – New research suggests that marijuana use may increase the risk of testicular germ cell tumors (TGCTs), primarily nonseminoma types. According to the report…
NEW YORK (Reuters Health) – After the development of coronary artery disease (CAD), a subsequent diagnosis of depression is associated with an increased incidence of heart failure, even…
NEW YORK (Reuters Health) – Despite the fact that up to one third of patients with severe dementia receive enteral tube feeding, evidence is lacking that this practice…
NEW YORK (Reuters Health) – Assessing kidney function with both the estimated glomerular filtration rate (eGFR) and with urinary albumin levels can help predict whether chronic kidney disease…
NEW YORK (Reuters Health) – Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, is a safe and effective treatment for hot flushes in postmenopausal women, according to a report in the…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
NEW YORK (Reuters Health) – Roughly one in five deaths after lumbar fusion surgery is related to analgesic use, according to a report in the April 1st issue…
NEW YORK (Reuters Health) – The progestin dienogest is as effective as the gonadotropin-releasing hormone agonist buserelin for symptoms of endometriosis, with less reduction in bone mass, physicians…
